Members Only Content

Subscribe to get full access

Free Preview

Illumina has replaced its CEO, its Chairman, and its strategic priorities. What will this mean for investors?

Genomic sequencing leader Illumina (Nasdaq: ILMN) has been in the news a lot lately. And for all the wrong reasons.

Our 7investing team was initially drawn to Illumina’s undisputed leadership position, accounting for for more than 90% of the world’s high-throughput sequencing volume and benefiting from scientific breakthroughs like CRISPR and government-funded precision medicine initiatives.

Yet the company has been under the gun this year. In April, the Federal Trade Commission demanded that Illumina divest its newly-re-acquired GRAIL subsidiary, believing it led to uncompetitive business practices. On top of that, activist investor Carl Icahn launched a proxy battle that ultimately resulted in replacing both the Chairman and the CEO.

What will all of this mean for investors? Now priced at a 52-week low, is Illumina’s stock still a buy?

7investing advisor Simon Erickson shares a deep-dive into Illumina’s history, an analysis of its current situation, and whether 7investing thinks the stock is a buy, hold, or sell in his complete Company Update.

Reminder: You must be logged in with an active 7investing membership to view this Company Updates. To get started with 7investing in 30 seconds and for just $1, please click here.

a button saying "Read Full company update"

related news & insights

  • 7investing logo next to the Upstart logo.
    June 12, 2025||0 min||||

    Upstart Deep Dive: June 2025

    Upstart Recommendation Report Upstart Presentation Slides

  • May 30, 2025||0.8 min||||

    7investing Exclusive: A Deep Dive Into Lemonade

    Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]

  • May 16, 2025||46.1 min||||

    What’s Next for Digital Advertising? 7investing Interviews PubMatic CEO Rajeev Goel

    PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]